DocGo (DCGO) Cash & Equivalents (2020 - 2026)

DocGo has reported Cash & Equivalents for 7 years, with the latest figure at $35.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 54.85% year-over-year to $35.7 million; the trailing twelve-month figure through Mar 2026 stood at $35.7 million (down 54.85% YoY), and the FY2025 full-year result was $51.0 million, down 42.83% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $35.7 million, down from $51.0 million in the prior quarter.
• The five-year high for Cash & Equivalents was $198.1 million in Q2 2022, with the low at $35.7 million in Q1 2026.
• Average Cash & Equivalents over 5 years is $99.1 million, with a median of $89.2 million recorded in 2024.
• Year-over-year, Cash & Equivalents soared 285809.66% in 2022 and plunged 68.8% in 2023.
• Tracing DCGO's Cash & Equivalents over 5 years: stood at $157.3 million in 2022, then sank by 62.32% to $59.3 million in 2023, then jumped by 50.53% to $89.2 million in 2024, then plunged by 42.83% to $51.0 million in 2025, then sank by 30.07% to $35.7 million in 2026.
• The last three Cash & Equivalents figures came in at $35.7 million (Q1 2026), $51.0 million (Q4 2025), and $73.4 million (Q3 2025), per Business Quant data.

Peer Comparison